A series of Notch3 mutations in CADASIL; insights from 3D molecular modelling and evolutionary analyses

Dimitrios Vlachakis; Spyridon Champeris Tsaniras; Katerina Ioannidou; Louis Papageorgiou; Marc Baumann; Sophia Kossida

A series of Notch3 mutations in CADASIL; insights from 3D molecular modelling and evolutionary analyses

Dimitrios Vlachakis, Spyridon Champeris Tsaniras, Katerina Ioannidou, Louis Papageorgiou, Marc Baumann, Sophia Kossida

Abstract

CADASIL disease belongs to the group of rare diseases. It is well established that the Notch3 protein is primarily responsible for the development of CADASIL syndrome. Herein, we attempt to shed light to the actual molecular mechanism underlying CADASIL via insights that we have from preliminary in silico and proteomics studies on the Notch3 protein. At the moment, we are aware of a series of Notch3 point mutations that promote CADASIL. In this direction, we investigate the nature, extent, physicochemical and structural significance of the mutant species in an effort to identify the underlying mechanism of Notch3 role and implications in cell signal transduction. Overall, our in silico study has revealed a rather complex molecular mechanism of Notch3 on the structural level; depending of the nature and position of each mutation, a consensus significant loss of beta-sheet structure is observed throughout all in silico modeled mutant/wild type biological systems.

Keywords

CADASIL; Notch3 mutations; Notch3 structure

References

Balatsos N, Vlachakis D, Chatzigeorgiou V, Manta S, Komiotis D, Vlassi M & Stathopoulos C 2012 Kinetic and in silico analysis of the slow-binding inhibition of human poly (A)-specific ribonuclease (PARN) by novel nucleoside analogues. Biochimie 94 1 214-221

Bellavia D, Checquolo S, Campese AF, Felli MP, Gulino A & Screpanti I 2008 Notch3: from subtle structural differences to functional diversity. Oncogene 27 5092-5098

Bersano A, Ranieri M, Ciammola A, Cinnante C, Lanfranconi S, Dotti MT, Candelise L, Baschirotto C, Ghione I, Ballabio E, Bresolin N & Bassi MT 2012 Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant. Funct Neurol 27 247-252

Boucher J, Gridley T & Liaw L 2012 Molecular Pathways of Notch Signaling in Vascular Smooth Muscle Cells. Front Physiol 3 81

Buffon F, Porcher R, Hernandez K, Kurtz A, Pointeau S, Vahedi K, Bousser MG & Chabriat H 2006 Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 77 175-180

Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X et al. 1995 Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 346 934-939

Consortium TU 2011 Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res 39 D214-D219

Cordle J1, Johnson S, Tay JZ, Roversi P, Wilkin MB, de Madrid BH, Shimizu H, Jensen S, Whiteman P, Jin B, Redfield C, Baron M, Lea SM & Handford PA 2008 A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat Struct Mol Biol 15 849-857

Crooks GE, Hon G, Chandonia JM & Brenner SE 2004 WebLogo: a sequence logo generator. Genome Res 14 1188-1190

Dalkas GA, Vlachakis D, Tsagkrasoulis D, Kastania A & Kossida S 2013 State-of-the-art technology in modern computer-aided drug design. Brief Bioinform 14 745-752

Dichgans M, Mayer M, Uttner I, Brüning R, Müller-Höcker J, Rungger G, Ebke M, Klockgether T & Gasser T 1998 The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44 731-739

Ferreira S, Costa C & Oliveira JP 2007 Novel human pathological mutations. Gene symbol: NOTCH3. Disease: cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Hum Genet 121 649

Fiuza UM & Arias AM 2007 Cell and molecular biology of Notch. J Endocrinol 194 459-474

Gordon WR, Arnett KL & Blacklow SC 2008 The molecular logic of Notch signaling – a structural and biochemical perspective. J Cell Sci 121 3109-3119

Hess B, Kutzner C, van der Spoel D & Lindahl E 2008 GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theor Comput 4 435-447

Ishiko A, Shimizu A, Nagata E, Takahashi K, Tabira T & Suzuki N 2006 Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol 112 333-339

Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG & Tournier-Lasserve E 1996 Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383 707-710

Joutel A, Dodick DD, Parisi JE, Cecillon M, Tournier-Lasserve E & Bousser MG 2000 De novo mutation in the NOTCH3 gene causing CADASIL. Ann Neurol 47 388-391

Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R & Thornton JM 1996 AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8 477-486

Lewandowska E, Dziewulska D, Parys M & Pasennik E 2011 Ultrastructure of granular osmiophilic material deposits (GOM) in arterioles of CADASIL patients. Folia Neuropathol 49 174-180

Loukatou S, Papageorgiou L, Fakourelis P, Filtisi A, Polychronidou E, Bassis I, Megalooikonomou V, Makalowski W, Vlachakis D & Kossida S 2014 Molecular dynamics simulations through GPU video games technologies. J Mol Biochem 3 64-71

Merkel JS & Regan L 1998 Aromatic rescue of glycine in beta sheets. Fold Des 3 449-455

Monet-Leprêtre M 2009 Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain 132 1601-1612

Papagelopoulos N, Vlachakis D, Filntisi A, Fakourelis P, Papageorgiou L, Megalooikonomou V & Kossida S 2014 State of the art GPGPU applications in bioinformatics. Int J Sys Biol Biomed Technol 2 24-48

Papageorgiou L, Vlachakis D, Koumandou VL, Papagelopoulos N & Kossida S 2014 Computer-Aided Drug Design and Biological Evaluation of Novel Anti-Greek Goat Encephalitis Agents. Int J Sys Biol Biomed Technol 2 1-16

Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D, Hess B & Lindahl E 2013 GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29 845-854

Razvi SS, Davidson R, Bone I & Muir KW 2005 The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 76 739-341

Robinson CR & Sauer RT 1998 Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. Proc Natl Acad Sci U S A 95 5929-5934

Sali A, Potterton L, Yuan F, van Vlijmen H & Karplus M 1995 Evaluation of comparative protein modeling by MODELLER. Proteins 23 318-326

Scheid R, Heinritz W, Leyhe T, Thal DR, Schober R, Strenge S, von Cramon DY & Froster UG 2008 Cysteine-sparing notch3 mutations: cadasil or cadasil variants? Neurology 71 774-776

Sellis D, Vlachakis D & Vlassi M 2009 Gromita: a fully integrated graphical user interface to gromacs 4. Bioinform Biol Ins 3 99-102

Sourander P & Walinder J 1977 Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease. Acta Neuropathol 39 247-254

Tatsch K, Koch W, Linke R, Poepperl G, Peters N, Holtmannspoetter M & Dichgans M 2003 Cortical hypometabolism and crossed cerebellar diaschisis suggest subcortically induced disconnection in CADASIL: an 18F-FDG PET study. J Nucl Med 44 862-869

Tikka S, Mykkänen K, Ruchoux MM, Bergholm R, Junna M, Pöyhönen M, Yki-Järvinen H, Joutel A, Viitanen M, Baumann M & Kalimo H 2009 Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 132 933-939

Toni-Uebari TK 2013 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL): a rare cause of dementia. BMJ Case Rep bcr2012007285

Tournier-Lasserve E1, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, Mas JL, Cabanis EA, Baudrimont M, Maciazek J, Bach MA & Bousser MG 1993 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3 256-259

Ueda M, Nakaguma R & Ando Y 2009 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)]. [Article in Japanese]. Rinsho Byori 57 242-251

Valenti R, Pescini F, Antonini S, Castellini G, Poggesi A, Bianchi S, Inzitari D, Pallanti S & Pantoni L 2011 Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview. Acta Neurol. Scand 124 390-395

Velizarova R, Mourand I, Serafini A, Crespel A & Gelisse P 2011 Focal epilepsy as first symptom in CADASIL. Seizure 20 502-504

Vlachakis D, Argiro A & Kossida S 2013a An update on virology and emerging viral epidemics. J Mol Biochem 2 80-84

Vlachakis D, Bencurova E, Papangelopoulos N & Kossida S 2014 Current State-of-the-Art Molecular Dynamics Methods and Applications. Adv Protein Chem Struct Biol 94 269-313

Vlachakis D, Karozou A & Kossida S 2013b 3D Molecular Modelling Study of the H7N9 RNA-Dependent RNA Polymerase as an Emerging Pharmacological Target. Influenza Res Treat 2013 645348

Vlachakis D, Kontopoulos DG & Kossida S 2013c. Space constrained homology modelling: the paradigm of the RNA-dependent RNA polymerase of dengue (type II) virus. Comput Math Methods Med 2013 108910

Vlachakis D & Kossida S 2013 Molecular modeling and pharmacophore elucidation study of the Classical Swine Fever virus helicase as a promising pharmacological target. PeerJ 1 e85

Vlachakis D, Koumandou VL & Kossida S 2013d A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase. PeerJ 1 e74

Vlachakis D, Pavlopoulou A, Tsiliki G, Komiotis D, Stathopoulos C, Balatsos NA & Kossida S 2012a An integrated in silico approach to design specific inhibitors targeting human poly(a)-specific ribonuclease. PLoS One 7 e51113

Vlachakis D, Tsaniras SC, Feidakis C & Kossida S 2013e Molecular modelling study of the 3D structure of the biglycan core protein, using homology modelling techniques. J Mol Biochem 2 85-93

Vlachakis D, Tsaniras SC & Kossida S 2012b Current viral infections and epidemics of flaviviridae; lots of grief but also some hope. J Mol Biochem 1 144-149

Vlachakis D, Tsiliki G & Kossida S 2013f 3D Molecular Modelling of the Helicase Enzyme of the Endemic, Zoonotic Greek Goat Encephalitis Virus. Comm Com Inf Sci 383 165-171

Vlachakis D, Tsiliki G, Pavlopoulou A, Roubelakis MG, Tsaniras SC & Kossida S 2013g Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology. Evol Bioinform Online 9 203-213

Yan BX & Sun YQ 1997 Glycine residues provide flexibility for enzyme active sites. J Biol Chem 272 3190-3194

Zhang T, Zhang H, Chen K, Shen S, Ruan J & Kurgan L 2008 Accurate sequence-based prediction of catalytic residues. Bioinformatics 24 2329-2338

Full Text: PDF

Refbacks

There are currently no refbacks.